[1
]
Medizinische Klinik und Poliklinik III (S.R.B., A.B.), Universitätsklinikum Dresden,
01307 Dresden, Germany; Department of Endocrinology and Diabetes (S.R.B.), King's
College London, London WC2R 2LS, United Kingdom; Department of Internal Medicine I
(B.A.), Endocrine and Diabetes Unit, University Hospital Würzburg, 97080 Würzburg,
Germany; Comprehensive Heart Failure Center (B.A.), University of Würzburg, 97080
Würzburg, Germany; Centre for Endocrinology, Diabetes, and Metabolism (W.A.), University
of Birmingham, Birmingham B15 2TT, United Kingdom; Endokrinologikum Ruhr (A.B.), 44866
Bochum, Germany; Department of Pathology and Molecular Medicine (A.D.-W.), McMaster
University, Hamilton, ON L8S 4L8, Canada; Hamilton Regional Laboratory Medicine Program
(A.D.-W.), Hamilton, ON L8N 4A6, Canada; Department of Internal Medicine (G.D.H.),
Division of Metabolism, Endocrinology, and Diabetes, and Cancer Center, University
of Michigan, Ann Arbor, Michigan 48109; Department of Clinical Science, University
of Bergen, and Department of Medicine, Haukeland University Hospital (E.S.H.), 5021
Bergen, Norway; National Institutes of Health Clinical Center (D.P.M.), Bethesda,
Maryland 20814; Mayo Clinic, Division of Preventive Medicine (M.H.M.), Rochester,
Minnesota 55905; Eunice Kennedy Shriver National Institute of Child Health and Human
Development (C.A.S.), National Institutes of Health, Bethesda, Maryland 20892; and
Endocrine and Metabolic Unit (D.J.T.), Royal Adelaide Hospital, University of Adelaide,
Adelaide SA 5000, Australia.
